ArticleOncoTargets and therapy2018

Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study.

Martin Reck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.